Avanos Medical recalls feeding tube kits over sterility concerns

ALPHARETTA, Ga. – Avanos Medical, Inc. (NYSE: NYSE:), a medical technology company, has issued a voluntary recall for specific lots of its MIC Gastric Jejunal Feeding Tube Kits, as announced on February 21, 2024. This recall is a direct consequence of a similar action taken by Nurse Assist, LLC regarding their pre-filled syringes and sterile water products, which are included in Avanos’ kits.

The recall by Nurse Assist was initiated over potential sterility assurance issues, which could lead to non-sterile products being used in medical settings. Such products pose an infection risk if they come into contact with a patient’s surgical site or any open wound. The FDA, as of February 6, 2024, has reported receiving adverse events related to the use of Nurse Assist’s products and is currently evaluating the information.

Avanos has not received direct reports of adverse events but has taken proactive measures to identify and recall the affected product codes and lot numbers of the feeding tube kits. The company has instructed customers who have received the affected lots to remove the kits from their facilities and take several actions, including reporting any adverse events, quarantining and destroying the affected products in inventory, and notifying other departments or customers of this recall.

The recall is limited to the pre-filled syringe component supplied by Nurse Assist, which is used for inflating the retention balloon of the feeding tube within the Avanos kit. The company has provided a list of affected product codes and lot numbers, as well as a customer response form, which can be accessed through a link provided in their recall statement.

Avanos Medical has taken steps to ensure patient safety by issuing this voluntary recall and is working closely with healthcare providers to manage the recall process efficiently. The information about the recall is based on a press release statement from Avanos Medical.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.